Works matching DE "BORTEZOMIB"

Results: 1587
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    Dose-dependent immunomodulatory effects of bortezomib in experimental autoimmune neuritis.

    Published in:
    Brain Communications, 2021, v. 3, n. 4, p. 1, doi. 10.1093/braincomms/fcab238
    By:
    • Klimas, Rafael;
    • Sgodzai, Melissa;
    • Motte, Jeremias;
    • Mohamad, Nuwin;
    • Renk, Pia;
    • Blusch, Alina;
    • Grüter, Thomas;
    • Pedreiturria, Xiomara;
    • Gobrecht, Philipp;
    • Fischer, Dietmar;
    • Schneider-Gold, Christiane;
    • Reinacher-Schick, Anke;
    • Tannapfel, Andrea;
    • Min-Suk Yoon;
    • Gold, Ralf;
    • Pitarokoili, Kalliopi
    Publication type:
    Article
    12
    13
    14
    15
    16

    An in vitro and in vivo investigation of the cytotoxic effects of caffeic acid (3,4-dihydroxycinnamic acid) phenethyl ester and bortezomib in multiple myeloma cells.

    Published in:
    Turkish Journal of Medical Sciences, 2015, v. 45, n. 1, p. 38, doi. 10.3906/sag-1401-127
    By:
    • ALTAYLI, Ertan;
    • KORU, Özgür;
    • ÖNGÖRÜ, Önder;
    • İDE, Tayfun;
    • AÇIKEL, Cengizhan;
    • SARPER, Meral;
    • ELÇİ, Mualla Pınar;
    • SAĞKAN, Rahşan ILIKÇI;
    • ASTARCI, Erhan;
    • TOK, Duran;
    • ÖZENÇ, Salim;
    • URAL, Ali Uğur;
    • AVCU, Ferit
    Publication type:
    Article
    17

    Chemotherapy-Induced Peripheral Neuropathy.

    Published in:
    Indian Journal of Pharmaceutical Education & Research, 2023, v. 57, n. 2, p. 342, doi. 10.5530/ijper.57.2.44
    By:
    • Jain, Ashish;
    • Hariprasad, M. G.;
    • Sharique, Mohammad;
    • Redhwan, Moqbel Ali Moqbel
    Publication type:
    Article
    18

    Treatment patterns of patients with triple-class exposed refractory/relapsed multiple myeloma in Poland -- preliminary results of multicentre observational POMOST study.

    Published in:
    Acta Haematologica Polonica, 2025, v. 56, n. 1, p. 48, doi. 10.5603/ahp.103294
    By:
    • Grząśko, Norbert;
    • Wałachowska, Beata;
    • Dytfeld, Dominik;
    • Gołos, Aleksandra;
    • Ziarkiewicz, Mateusz;
    • Waszczuk-Gajda, Anna;
    • Węglarz, Patryk;
    • Czyżewska, Maria;
    • Olszewska-Szopa, Magdalena;
    • Tyczyńska, Agata;
    • Dołęga-Talacha, Karolina;
    • Jurczyszyn, Artur;
    • Butrym, Aleksandra;
    • Urbanowicz, Alina;
    • Druzd-Sitek, Agnieszka
    Publication type:
    Article
    19
    20
    21
    22
    23

    Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study.

    Published in:
    Immunity, Inflammation & Disease, 2020, v. 8, n. 3, p. 342, doi. 10.1002/iid3.315
    By:
    • Rahman, Mohummad A.;
    • Brekke, Jorunn;
    • Arnesen, Victoria;
    • Hannisdal, Marianne H.;
    • Navarro, Andrea G.;
    • Waha, Andreas;
    • Herfindal, Lars;
    • Rygh, Cecilie B.;
    • Bratland, Eirik;
    • Brandal, Petter;
    • Haasz, Judit;
    • Oltedal, Leif;
    • Miletic, Hrvoje;
    • Lundervold, Arvid;
    • Lie, Stein A.;
    • Goplen, Dorota;
    • Chekenya, Martha
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Predictors and Profile of Severe Infectious Complications in Multiple Myeloma Patients Treated with Daratumumab-Based Regimens: A Machine Learning Model for Pneumonia Risk.

    Published in:
    Cancers, 2024, v. 16, n. 21, p. 3709, doi. 10.3390/cancers16213709
    By:
    • Mikulski, Damian;
    • Kędzior, Marcin Kamil;
    • Mirocha, Grzegorz;
    • Jerzmanowska-Piechota, Katarzyna;
    • Witas, Żaneta;
    • Woźniak, Łukasz;
    • Pawlak, Magdalena;
    • Kościelny, Kacper;
    • Kośny, Michał;
    • Robak, Paweł;
    • Gołos, Aleksandra;
    • Robak, Tadeusz;
    • Fendler, Wojciech;
    • Góra-Tybor, Joanna
    Publication type:
    Article
    47
    48

    Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 Trial.

    Published in:
    Cancers, 2024, v. 16, n. 8, p. 1448, doi. 10.3390/cancers16081448
    By:
    • van Dijk, Anneke D.;
    • Hoff, Fieke W.;
    • Qiu, Yihua;
    • Hubner, Stefan E.;
    • Go, Robin L.;
    • Ruvolo, Vivian R.;
    • Leonti, Amanda R.;
    • Gerbing, Robert B.;
    • Gamis, Alan S.;
    • Aplenc, Richard;
    • Kolb, Edward A.;
    • Alonzo, Todd A.;
    • Meshinchi, Soheil;
    • de Bont, Eveline S. J. M.;
    • Horton, Terzah M.;
    • Kornblau, Steven M.
    Publication type:
    Article
    49
    50